Sources | Names Used |
---|---|
CTRPv2 | BRD-K66532283 |
PharmacoGx | BRD-K66532283 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PEX16 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | IBA57 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | HACE1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | FGF19 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | ADPRM | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | RP11-451G4.2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | SYT1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | MTA1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | HLA-DRA | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | NUDT11 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |